Suppr超能文献

基于假型HIV-1的基因转移载体的生产与浓缩

Production and concentration of pseudotyped HIV-1-based gene transfer vectors.

作者信息

Reiser J

机构信息

Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

出版信息

Gene Ther. 2000 Jun;7(11):910-3. doi: 10.1038/sj.gt.3301188.

Abstract

Strategies to generate highly concentrated HIV-1 vector pseudotypes involving different envelope (Env) proteins including the vesicular stomatitis virus (VSV) G glycoprotein, the Moloney murine leukemia virus (MLV) 4070A amphotropic Env and the rabies G glycoprotein were established. Virus stocks were prepared by transient transfection using standard cell culture media or serum-free media. Such stocks were concentrated 50- to 300-fold by ultracentrifugation or by ultrafiltration using Centricon Plus-80 units yielding titers of up to 109transducing units per milliliter. There was no loss in titer with any of the pseudotypes tested. Thus, like lentiviral vectors pseudotyped with VSV-G, HIV-1-based vectors pseudotyped with the MLV 4070A amphotropic Env and the rabies G glycoprotein resist inactivation during concentration. This opens up the possibility to generate highly concentrated HIV-1 vector stocks carrying alternative Env proteins on a large scale.

摘要

已建立了产生高浓度HIV-1载体假型的策略,这些策略涉及不同的包膜(Env)蛋白,包括水泡性口炎病毒(VSV)G糖蛋白、莫洛尼鼠白血病病毒(MLV)4070A嗜异性Env和狂犬病G糖蛋白。通过使用标准细胞培养基或无血清培养基进行瞬时转染来制备病毒原液。通过超速离心或使用Centricon Plus-80装置进行超滤,将这些原液浓缩50至300倍,得到的滴度高达每毫升109个转导单位。所测试的任何假型的滴度均无损失。因此,与用VSV-G假型化的慢病毒载体一样,用MLV 4070A嗜异性Env和狂犬病G糖蛋白假型化的基于HIV-1的载体在浓缩过程中抗失活。这为大规模产生携带替代Env蛋白的高浓度HIV-1载体原液开辟了可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验